Through
5/7
A round-up of Penn mentions in local, national, and international media.
Penn In the News
In an op-ed, Jason Karlawish of the Perelman School of Medicine outlines the reliable process required to properly evaluate the effects of lecanemab, a new Alzheimer’s drug already approved by the FDA.
Penn In the News
In an op-ed, the Perelman School of Medicine’s Atheendar Venkataramani, Eugenia C. South, and George Dalembert, also of the Children’s Hospital of Philadelphia, write that health systems are uniquely positioned as economic engines to address the racial wealth gap.
Penn In the News
Anand Shah of the Leonard Davis Institute of Health Economics co-authored an op-ed stating that the government should provide the FDA with explicit authority to regulate e-cigarettes and additional products associated with tobacco harm.
Penn In the News
PIK Professor and Vice Provost for Penn Global Ezekiel Emanuel says Fauci and the role he is leaving require someone able to translate science for the public and policy makers.
Penn In the News
Holly Fernandez Lynch, Steven Joffe, and Emily A. Largent of the Perelman School of Medicine write that ethics committees are not intended to second-guess clinical judgements about medical procedures or provide legal cover for institutions.
Penn In the News
Perelman School of Medicine’s Taku Kambayashi comments on a “serendipitous” finding in a Type 2 diabetes experiment.
Penn In the News
Scott Hensley and Paul Offit of the Perelman School of Medicine weighed in on the authorization of COVID-19 booster shots. “Anyone who thinks that vaccinating Americans with a third dose is not going to come at the expense of getting the vaccine to other places in the world—if that’s what you think, you’re just kidding yourself,” Hensley said.
Penn In the News
Salimah Meghani of the School of Nursing commented on a study that found that white patients are prescribed opioids more frequently and in greater quantities than Black patients within the same health system. Because the study was conducted using data from before the CDC’s revised opioid prescription guidelines, it “may be underestimating the actual size of disparities,” she said.
Penn In the News
Alison Buttenheim of the School of Nursing weighed in on the stop-and-start rollout of AstraZeneca’s COVID-19 vaccine, as well as how to communicate risk without unnecessarily sowing fear. “The stories, the anecdotes, are always going to be more memorable for people,” she said. “We have a harder story to tell about numbers and ratios and protocols and biological plausibility. So we have to get it right and prepare people.”
Penn In the News
Eve Higginbotham of the Perelman School of Medicine was interviewed about her new report, which found that the pandemic has impeded the careers of women in STEMM. “STEMM can’t exist without women, and women need to have the support of a more robust infrastructure within institutions to be able to have the optimal vitality so that we can succeed,” she said.